Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02289989Terminated
Randomised, double-blind trial in atopic dermatitis (AD) (2 arms), sponsored by Rutgers University. Primary endpoints: Clinical Efficacy Rated by the Patient or Caregiver at Day 25, Change of the Clinical Efficacy Rated by a Study Physician at Day 28 and 1 more. Started Nov 2014; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02289989.